Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma

Accumulation of malignant plasma cells in the bone marrow causes lytic bone lesions in 80% of multiple myeloma patients. Frequently fracturing, they are challenging to treat surgically. Myeloma cells surviving treatment in the presumably protective environment of bone lesions impede their healing by...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hose, Dirk (VerfasserIn) , Ray, Seemun (VerfasserIn) , Rößler, Sina (VerfasserIn) , Thormann, Ulrich (VerfasserIn) , Schnettler, Reinhard (VerfasserIn) , De Veirman, Kim (VerfasserIn) , Khassawna, Thaqif el- (VerfasserIn) , Heiss, Christian (VerfasserIn) , Hild, Anne (VerfasserIn) , Zahner, Daniel (VerfasserIn) , Alagboso, Francisca (VerfasserIn) , Henss, Anja (VerfasserIn) , Beck, Susanne (VerfasserIn) , Emde-Rajaratnam, Martina (VerfasserIn) , Burhenne, Jürgen (VerfasserIn) , Bamberger, Juliane (VerfasserIn) , Menu, Eline (VerfasserIn) , de Bruyne, Elke (VerfasserIn) , Gelinsky, Michael (VerfasserIn) , Kampschulte, Marian (VerfasserIn) , Rohnke, Marcus (VerfasserIn) , Wenisch, Sabine (VerfasserIn) , Vanderkerken, Karin (VerfasserIn) , Hanke, Thomas (VerfasserIn) , Seckinger, Anja (VerfasserIn) , Alt, Volker (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 18 December 2024
In: Journal of hematology & oncology
Year: 2024, Jahrgang: 17, Pages: 1-20
ISSN:1756-8722
DOI:10.1186/s13045-024-01636-4
Online-Zugang:Resolving-System, kostenfrei, Volltext: https://doi.org/10.1186/s13045-024-01636-4
Verlag, kostenfrei, Volltext: https://jhoonline.biomedcentral.com/articles/10.1186/s13045-024-01636-4
Volltext
Verfasserangaben:Dirk Hose, Seemun Ray, Sina Rößler, Ulrich Thormann, Reinhard Schnettler, Kim de Veirman, Thaqif El Khassawna, Christian Heiss, Anne Hild, Daniel Zahner, Francisca Alagboso, Anja Henss, Susanne Beck, Martina Emde-Rajaratnam, Jürgen Burhenne, Juliane Bamberger, Eline Menu, Elke de Bruyne, Michael Gelinsky, Marian Kampschulte, Marcus Rohnke, Sabine Wenisch, Karin Vanderkerken, Thomas Hanke, Anja Seckinger and Volker Alt

MARC

LEADER 00000caa a2200000 c 4500
001 1920179771
003 DE-627
005 20250717001959.0
007 cr uuu---uuuuu
008 250320s2024 xx |||||o 00| ||eng c
024 7 |a 10.1186/s13045-024-01636-4  |2 doi 
035 |a (DE-627)1920179771 
035 |a (DE-599)KXP1920179771 
035 |a (OCoLC)1528043456 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hose, Dirk  |d 1969-  |e VerfasserIn  |0 (DE-588)139824995  |0 (DE-627)613790308  |0 (DE-576)313431698  |4 aut 
245 1 0 |a Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma  |c Dirk Hose, Seemun Ray, Sina Rößler, Ulrich Thormann, Reinhard Schnettler, Kim de Veirman, Thaqif El Khassawna, Christian Heiss, Anne Hild, Daniel Zahner, Francisca Alagboso, Anja Henss, Susanne Beck, Martina Emde-Rajaratnam, Jürgen Burhenne, Juliane Bamberger, Eline Menu, Elke de Bruyne, Michael Gelinsky, Marian Kampschulte, Marcus Rohnke, Sabine Wenisch, Karin Vanderkerken, Thomas Hanke, Anja Seckinger and Volker Alt 
264 1 |c 18 December 2024 
300 |b Illustrationen 
300 |a 20 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 20.03.2025 
520 |a Accumulation of malignant plasma cells in the bone marrow causes lytic bone lesions in 80% of multiple myeloma patients. Frequently fracturing, they are challenging to treat surgically. Myeloma cells surviving treatment in the presumably protective environment of bone lesions impede their healing by continued impact on bone turnover and can explain regular progression of patients without detectable minimal residual disease (MRD). Locally applicable biomaterials could stabilize and foster healing of bone defects, simultaneously delivering anti-cancer compounds at systemically intolerable concentrations, overcoming drug resistance. 
650 4 |a Bone substitute material 
650 4 |a Bortezomib 
650 4 |a Local treatment 
650 4 |a Minimal residual disease 
650 4 |a Multiple myeloma 
650 4 |a Osteolytic bone lesions 
700 1 |a Ray, Seemun  |e VerfasserIn  |4 aut 
700 1 |a Rößler, Sina  |d 1989-  |e VerfasserIn  |0 (DE-588)1242050264  |0 (DE-627)1771953144  |4 aut 
700 1 |a Thormann, Ulrich  |d 1979-  |e VerfasserIn  |0 (DE-588)133458768  |0 (DE-627)69146734X  |0 (DE-576)299862186  |4 aut 
700 1 |a Schnettler, Reinhard  |d 1945-  |e VerfasserIn  |0 (DE-588)143579886  |0 (DE-627)704534622  |0 (DE-576)172856221  |4 aut 
700 1 |a De Veirman, Kim  |e VerfasserIn  |0 (DE-588)1166881474  |0 (DE-627)1030758263  |0 (DE-576)51093918X  |4 aut 
700 1 |a Khassawna, Thaqif el-  |e VerfasserIn  |0 (DE-588)1037442407  |0 (DE-627)755749235  |0 (DE-576)391477005  |4 aut 
700 1 |a Heiss, Christian  |e VerfasserIn  |4 aut 
700 1 |a Hild, Anne  |e VerfasserIn  |4 aut 
700 1 |a Zahner, Daniel  |e VerfasserIn  |4 aut 
700 1 |a Alagboso, Francisca  |e VerfasserIn  |4 aut 
700 1 |a Henss, Anja  |e VerfasserIn  |4 aut 
700 1 |a Beck, Susanne  |e VerfasserIn  |4 aut 
700 1 |a Emde-Rajaratnam, Martina  |d 1988-  |e VerfasserIn  |0 (DE-588)116096193X  |0 (DE-627)1024350673  |0 (DE-576)506290433  |4 aut 
700 1 |a Burhenne, Jürgen  |d 1963-  |e VerfasserIn  |0 (DE-588)1034228889  |0 (DE-627)745126987  |0 (DE-576)381858197  |4 aut 
700 1 |a Bamberger, Juliane  |e VerfasserIn  |4 aut 
700 1 |a Menu, Eline  |e VerfasserIn  |4 aut 
700 1 |a de Bruyne, Elke  |e VerfasserIn  |4 aut 
700 1 |a Gelinsky, Michael  |e VerfasserIn  |4 aut 
700 1 |a Kampschulte, Marian  |e VerfasserIn  |4 aut 
700 1 |a Rohnke, Marcus  |e VerfasserIn  |4 aut 
700 1 |a Wenisch, Sabine  |d 1962-  |e VerfasserIn  |0 (DE-588)143580264  |0 (DE-627)704534681  |0 (DE-576)337810524  |4 aut 
700 1 |a Vanderkerken, Karin  |e VerfasserIn  |4 aut 
700 1 |a Hanke, Thomas  |e VerfasserIn  |4 aut 
700 1 |a Seckinger, Anja  |d 1980-  |e VerfasserIn  |0 (DE-588)134177371  |0 (DE-627)562118225  |0 (DE-576)278603734  |4 aut 
700 1 |a Alt, Volker  |d 1970-  |e VerfasserIn  |0 (DE-588)123694574  |0 (DE-627)082712468  |0 (DE-576)293830452  |4 aut 
773 0 8 |i Enthalten in  |t Journal of hematology & oncology  |d London : Biomed Central, 2008  |g 17(2024), Artikel-ID 128, Seite 1-20  |h Online-Ressource  |w (DE-627)568914813  |w (DE-600)2429631-4  |w (DE-576)281703132  |x 1756-8722  |7 nnas  |a Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma 
773 1 8 |g volume:17  |g year:2024  |g elocationid:128  |g pages:1-20  |g extent:20  |a Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma 
787 0 8 |i Errata  |a Hose, Dirk, 1969 -   |t Correction: Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma  |d 2025  |w (DE-627)192018080X 
856 4 0 |u https://doi.org/10.1186/s13045-024-01636-4  |x Resolving-System  |x Verlag  |z kostenfrei  |3 Volltext 
856 4 0 |u https://jhoonline.biomedcentral.com/articles/10.1186/s13045-024-01636-4  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250320 
993 |a Article 
994 |a 2024 
998 |g 134177371  |a Seckinger, Anja  |m 134177371:Seckinger, Anja  |d 50000  |e 50000PS134177371  |k 0/50000/  |p 25 
998 |g 1034228889  |a Burhenne, Jürgen  |m 1034228889:Burhenne, Jürgen  |d 910000  |d 910100  |e 910000PB1034228889  |e 910100PB1034228889  |k 0/910000/  |k 1/910000/910100/  |p 15 
998 |g 139824995  |a Hose, Dirk  |m 139824995:Hose, Dirk  |d 910000  |d 910100  |d 50000  |e 910000PH139824995  |e 910100PH139824995  |e 50000PH139824995  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1920179771  |e 4688527314 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"title":[{"title_sort":"Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma","title":"Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma"}],"name":{"displayForm":["Dirk Hose, Seemun Ray, Sina Rößler, Ulrich Thormann, Reinhard Schnettler, Kim de Veirman, Thaqif El Khassawna, Christian Heiss, Anne Hild, Daniel Zahner, Francisca Alagboso, Anja Henss, Susanne Beck, Martina Emde-Rajaratnam, Jürgen Burhenne, Juliane Bamberger, Eline Menu, Elke de Bruyne, Michael Gelinsky, Marian Kampschulte, Marcus Rohnke, Sabine Wenisch, Karin Vanderkerken, Thomas Hanke, Anja Seckinger and Volker Alt"]},"person":[{"role":"aut","given":"Dirk","display":"Hose, Dirk","family":"Hose"},{"family":"Ray","display":"Ray, Seemun","role":"aut","given":"Seemun"},{"role":"aut","given":"Sina","display":"Rößler, Sina","family":"Rößler"},{"family":"Thormann","display":"Thormann, Ulrich","given":"Ulrich","role":"aut"},{"family":"Schnettler","display":"Schnettler, Reinhard","role":"aut","given":"Reinhard"},{"display":"De Veirman, Kim","role":"aut","given":"Kim","family":"De Veirman"},{"display":"Khassawna, Thaqif el-","role":"aut","given":"Thaqif el-","family":"Khassawna"},{"family":"Heiss","role":"aut","given":"Christian","display":"Heiss, Christian"},{"family":"Hild","given":"Anne","role":"aut","display":"Hild, Anne"},{"family":"Zahner","display":"Zahner, Daniel","role":"aut","given":"Daniel"},{"display":"Alagboso, Francisca","role":"aut","given":"Francisca","family":"Alagboso"},{"display":"Henss, Anja","given":"Anja","role":"aut","family":"Henss"},{"family":"Beck","given":"Susanne","role":"aut","display":"Beck, Susanne"},{"display":"Emde-Rajaratnam, Martina","given":"Martina","role":"aut","family":"Emde-Rajaratnam"},{"display":"Burhenne, Jürgen","given":"Jürgen","role":"aut","family":"Burhenne"},{"family":"Bamberger","given":"Juliane","role":"aut","display":"Bamberger, Juliane"},{"family":"Menu","given":"Eline","role":"aut","display":"Menu, Eline"},{"given":"Elke","role":"aut","display":"de Bruyne, Elke","family":"de Bruyne"},{"display":"Gelinsky, Michael","role":"aut","given":"Michael","family":"Gelinsky"},{"family":"Kampschulte","display":"Kampschulte, Marian","given":"Marian","role":"aut"},{"given":"Marcus","role":"aut","display":"Rohnke, Marcus","family":"Rohnke"},{"display":"Wenisch, Sabine","role":"aut","given":"Sabine","family":"Wenisch"},{"display":"Vanderkerken, Karin","role":"aut","given":"Karin","family":"Vanderkerken"},{"family":"Hanke","given":"Thomas","role":"aut","display":"Hanke, Thomas"},{"family":"Seckinger","role":"aut","given":"Anja","display":"Seckinger, Anja"},{"display":"Alt, Volker","role":"aut","given":"Volker","family":"Alt"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"18 December 2024","dateIssuedKey":"2024"}],"recId":"1920179771","note":["Gesehen am 20.03.2025"],"relHost":[{"note":["Gesehen am 19.06.2020"],"disp":"Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myelomaJournal of hematology & oncology","id":{"eki":["568914813"],"zdb":["2429631-4"],"issn":["1756-8722"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"2008-","publisher":"Biomed Central","dateIssuedKey":"2008","publisherPlace":"London"}],"recId":"568914813","titleAlt":[{"title":"Journal of hematology and oncology"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"part":{"volume":"17","text":"17(2024), Artikel-ID 128, Seite 1-20","year":"2024","pages":"1-20","extent":"20"},"title":[{"title_sort":"Journal of hematology & oncology","title":"Journal of hematology & oncology"}],"pubHistory":["1.2008 -"]}],"id":{"doi":["10.1186/s13045-024-01636-4"],"eki":["1920179771"]},"physDesc":[{"noteIll":"Illustrationen","extent":"20 S."}]} 
SRT |a HOSEDIRKRABORTEZOMIB1820